You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


No survival benefit from aspirin in COVID-19 patients

Findings of the UK RECOVERY trial show that use of aspirin in the hope of reducing blood clotting in patients hospitalised with COVID-19 does not have any impact on survival.